20776-48-1Nc1cccc(Br)c1C(=O)OBNQPROAXWQCNKO-UHFFFAOYSA-N20776-48-1DTXSID80441750Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 40% (6 of 15) of reports.
Warning
H315 (53.3%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 15 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Verwenden2-Amino-6-bromobenzoic acid serves as a precursor to 5-bromo-2H-3,1-benzoxazine-2,4(1H)-dione (6-bromoisatoic anhydride), formed by treatment with sodium hydroxide and phosgene at 0 °C[1]. The compound condenses with 2-fluorobenzaldehyde to give 5-bromo-2-(2-fluorophenyl)-1,2-dihydro-4H-benzo[d][1,3]oxazin-4-one in 88% yield, and with methylamine in the presence of EDCI and HOBt to afford an amide intermediate that undergoes self-condensation en route to anthranilic diamide analogues. Its hydrochloride is reacted with N,O-dimethylhydroxylamine hydrochloride in DMF under nitrogen to synthesize 2-amino-X-bromo-N-methoxy-N-methylbenzamides[2].